Tucson Myofilament Meeting, May 23-26

The Tucson Myofilament Meeting is an international 3.5-day Sarver Heart Center conference that brings together approximately 250 scientists focused on the structure and function of the myofilaments that comprise the contractile machinery of muscle. Spanning topics from molecular biophysics to heart and skeletal muscle disease mechanisms and drug development, the meeting is known for its highly interactive, collaborative, and informal atmosphere, with strong engagement of early career investigators.

Traditionally held biennially at the University of Wisconsin, the meeting will continue at the University of Arizona beginning in May 2026, offering a distinctive Tucson setting that fosters scientific exchange and community building.

Learn More and Register

Hesham A. Sadek, MD, PhD

Professor, Medicine
Professor, Department of Cellular & Molecular Medicine
Chief, Division of Cardiology
Director, Sarver Heart Center
Allan C. Hudson & Helen Lovaas – Endowed Chair of Cardiovascular Medicine

Hesham A. Sadek was appointed as the new director of the Sarver Heart Center in May of 2024, bringing with him an impressive research portfolio from UT Southwestern Medical Center in Dallas. He previously served as associate director of the Center for Regenerative Science and Medicine and a professor of internal medicine/cardiology with joint appointments in biophysics and molecular biology.

Dr. Sadek's work has been continuously funded by the National Institutes of Health since 2011, and his clinical expertise in echocardiography and heart muscle function ensures that cutting-edge research translates into superior patient care. Sadek also is associate editor of the cardiovascular journal Circulation and serves on several American Heart Association committees. 

 

Research Interests: 

Dr. Sadek is recognized internationally for his research into the activation of mechanisms involved in the regeneration of damaged heart muscle. His seminal discovery of the newborn mammalian heart’s ability to regenerate has significantly altered the landscape of cardiac biology. His current research includes repurposing FDA-approved drugs to enhance heart regeneration and address rare genetic mutations causing heart failure. 

Primary College, Department: